PHA Live is a monthly series of Facebook Live events and webinars that provides an opportunity for those affected by pulmonary hypertension (PH) to hear from experts on health, wellness, science and research topics. Recordings of PHA Live events will become available on this page within three business days of the original program.

Upcoming Events

PH and HIV
Wednesday, Dec. 8 at 3:30 p.m. EST

Join the Pulmonary Hypertension Association (PHA) for the PHA Live event “PH and HIV” on Wednesday, Dec. 8 at 3:30 p.m. EST. As human immunodeficiency virus (HIV) treatments improve and patients live longer, more people with HIV are developing cardiovascular diseases, including pulmonary arterial hypertension (PAH). Christopher F. Barnett, M.D., M.P.H., will discuss the risk for developing PAH in people with HIV, how it is diagnosed and current treatment options.

Participants may email us any questions they would like addressed during the event by Monday, Dec. 6.

Register Now!

About the Speaker

Christopher F. Barnett, M.D., M.P.H
Christopher F. Barnett, M.D., M.P.H., is professor of clinical medicine at the University of California, San Francisco. Dr. Barnett earned his medical degree at Northwestern University and completed his residency in internal medicine at Northwestern Memorial Hospital. He completed a clinical and research fellowship in critical care medicine at the National Institutes of Health followed by a cardiology fellowship at the University of San Diego. Dr. Barnett has run pulmonary hypertension (PH) patient support groups and has been actively involved with PHA since 2011.

Additional Resource: “Pulmonary Hypertension and HIV

PHA thanks Janssen Pharmaceuticals for its Diamond Sponsorship of the Associated Disease Outreach & Engagement Program, which provides support to this PHA Live event.

Watch Previous PHA Live Events

2021-11-17T14:59:40-05:00

PH and Left Heart Disease

Vineet Agrawal, M.D., Ph.D., discusses left heart disease and the various ways it can lead to pulmonary hypertension (PH), highlights the importance of accurate diagnosis and shares treatment options. PHA thanks Janssen Pharmaceuticals for its Diamond sponsorship of the Associated Disease Outreach & Engagement Program, which provides support to this PHA Live event. 

2021-10-29T15:08:45-04:00

PH and Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Ivan Robbins, M.D., discusses CTEPH, highlights the importance of diagnosis and shares treatment options for individuals with pulmonary hypertension (PH) related to chronic thromboembolic disease. PHA thanks Janssen Pharmaceuticals for its Diamond sponsorship and Bayer HealthCare for its Platinum sponsorship of the PHA Connects Fund, which provides support to this PHA Live event.

2021-09-17T07:56:48-04:00

PH and Congenital Heart Disease

John T. Berger III, M.D., discusses congenital heart disease (CHD) and reviews types of heart and blood vessel abnormalities that can develop before a person is born that could lead to pulmonary hypertension (PH). PHA thanks Janssen Pharmaceuticals for its Diamond Sponsorship of the Associated Disease Outreach & Engagement Program, which provides support to this PHA Live event.

2021-08-19T15:29:20-04:00

A Conversation About the PHA Registry

Dan Grinnan, M.D., speaks with one of his pulmonary hypertension (PH) patients, Shirl Rhodes, about her enrollment in the PHA Registry (PHAR), a registry of patients with pulmonary arterial hypertension (PAH), pediatric PH due to developmental lung disease and chronic thromboembolic pulmonary hypertension (CTEPH). Learn what it is like to participate in the PHAR and how PHAR supports PH research. PHA thanks Bayer for its Platinum Sponsorship and Janssen Pharmaceuticals, Inc. for its Diamond Sponsorship of the PHA Connects fund, which provides support to this PHA Live event.

2021-07-30T11:35:06-04:00

PHA Research Room Findings

Scientists and clinicians present findings from the 2018 PHA Research Room, the Pulmonary Hypertension Association (PHA)’s research project providing pulmonary hypertension (PH) patients the opportunity to participate in clinical research studies. Learn about pulmonary arterial hypertension (PAH) biomarkers, patient survey results from support group therapy, an outcomes risk assessment tool for PH patients and barriers to exercise therapy in PH. PHA thanks Bayer for its Platinum Sponsorship and Janssen Pharmaceuticals, Inc. for its Diamond Sponsorship of the PHA Connects fund, which provides support to this PHA Live event.

2021-04-01T15:19:17-04:00

PH and Your Child

Dr. Eric Austin discusses how pulmonary hypertension (PH) affects children and answers common questions about heritable pulmonary atrial hypertension (PAH). The event will help parents to understand how pediatric PH is treated. PHA thanks Janssen Pharmaceuticals, Inc. for its diamond sponsorship of the PHA Connects fund, which provides support to this PHA Live event.

PHA thanks Janssen Pharmaceuticals, Inc. for its diamond sponsorship and Bayer for its platinum sponsorship of the PHA Connects fund, which provides support to this PHA Live event.